Similar articles

• [Mutation of p53 gene and expression of alphafetoprotein during hepatocarcinogenesis].

  Zou HQ, Tang ZY, Ye SL. Zou HQ, et al. Zhonghua Yi Xue Za Zhi. 1994 Aug;74(8):474-5, 517-8. Zhonghua Yi Xue Za Zhi. 1994. PMID: 7527728 Chinese.
• Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.

  Murakami Y, Hayashi K, Hirohashi S, Sekiya T. Murakami Y, et al. Cancer Res. 1991 Oct 15;51(20):5520-5. Cancer Res. 1991. PMID: 1655254
• INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.

  Tannapfel A, Busse C, Weinans L, Benicke M, Katalinic A, Geissler F, Hauss J, Wittekind C. Tannapfel A, et al. Oncogene. 2001 Oct 25;20(48):7104-9. doi: 10.1038/sj.onc.1204902. Oncogene. 2001. PMID: 11704835
• [Oncogenes and suppressor oncogenes in C-type hepatocellular carcinoma].

  Tsukiyama-Kohara K. Tsukiyama-Kohara K. Nihon Rinsho. 2004 Jul;62 Suppl 7(Pt 1):619-23. Nihon Rinsho. 2004. PMID: 15359872 Review. Japanese. No abstract available.
• [Gene TP53 and digestive cancers].

  Tominaga O, Salmon RJ, Laurent-Puig P. Tominaga O, et al. Gastroenterol Clin Biol. 1993;17(3):187-96. Gastroenterol Clin Biol. 1993. PMID: 8392475 Review. French. No abstract available.